Michael Burgess actually said...

Thank you for your leadership. You have done great work.

I want to thank the FDA and the industry and patient advocates and providers and other stakeholders for their work on this agreement.

It is vital that the Food and Drug Administration routinely incorporate the patient perspective in its decisionmaking process.

Reauthorizing the Medical Device User Fee Agreements and the user fee programs we have previously discussed would increase efficiency at FDA...